Speaker Profile
M.D., Executive Director Human Genetics, Genentech
Biography
Mark McCarthy is Executive Director of Human Genetics at Genentech, where he leads efforts within the company to use human genetics to advance the understanding of disease and further the development of novel therapeutic and preventative approaches. Prior to his move to the Bay Area in 2019, Mark was Robert Turner Professor of Diabetes Medicine at the University of Oxford. There, his research focused on genetic discovery in type 2 diabetes and related traits, and on using the causal insights derived from those analyses to drive biological inference and translational opportunities.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Mark Daly, Broad Institute (implied from context, but you didn’t restate – leaving just content here as requested)
PMWC Award Ceremony
• Mark Daly, Broad Institute
• Gordon Sanghera, Oxford Nanopore
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley/UCSC
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
• Barrett Bready, Nabsys
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute/FinnGen
AI and Evolution for Predicting Human Disease Genes
• Chair: Yuval Tabach, Hebrew University
• Nilah Ioannidis, UC Berkeley/UCSC
• Sasa Jenko, European Commission
DNA to Drug, Label & Coverage: From Genetic Signals to Approval & Access
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B Altman, Stanford
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
25+ Years of the Human Genome — From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
